These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4369322)

  • 1. The interaction of vasoactive intestinal polypeptide and secretin with liver-cell membranes.
    Desbuquois B
    Eur J Biochem; 1974 Aug; 46(3):439-50. PubMed ID: 4369322
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes.
    Desbuguois B; Laudat MH; Laudat P
    Biochem Biophys Res Commun; 1973 Aug; 53(4):1187-94. PubMed ID: 4356054
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of specific binding sites for vasoactive intestinal peptide in rat intestinal epithelial cell membranes.
    Amiranoff B; Laburthe M; Rosselin G
    Biochim Biophys Acta; 1980 Jan; 627(2):215-24. PubMed ID: 7350925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epinephrine binding by rat liver plasma membranes: effect of guanyl nucleotides.
    Lacombe ML; Hanoune J
    Biochem Biophys Res Commun; 1974 Jul; 59(2):474-81. PubMed ID: 4368689
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
    Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of kidney plasma membrane adenosine-3',5'-monophosphate-dependent protein kinase.
    Forte LR; Chao WT; Walkenbach J; Byington KH
    Biochim Biophys Acta; 1975 Apr; 389(1):84-96. PubMed ID: 166673
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
    Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues.
    Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J
    Digestion; 1982; 23(3):201-10. PubMed ID: 6286393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of binding sites for guanine nucleotides with adenylate cyclase activation in rat pancreatic plasma membranes. Interaction of gastrointestinal hormones.
    Svoboda M; Robberecht P; Camus J; Deschodt-Lanckman M; Christophe J
    Eur J Biochem; 1978 Feb; 83(1):287-97. PubMed ID: 627213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of Ca 2+ and Mg 2+ on the adenyl cyclase of beef brain.
    Bradham LS
    Biochim Biophys Acta; 1972 Aug; 276(2):434-43. PubMed ID: 4341589
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenaline-sensitive adenylate cyclase of human fat cell ghosts: properties and hormone-sensitivity.
    Kather H; Geiger M
    Eur J Clin Invest; 1977 Oct; 7(5):363-71. PubMed ID: 21796
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase.
    Bataille D; Freychet P; Rosselin G
    Endocrinology; 1974 Sep; 95(3):713-21. PubMed ID: 4368831
    [No Abstract]   [Full Text] [Related]  

  • 15. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
    Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PACAP-preferring receptors in human hyperplastic prostate.
    Carmena MJ; Solano RM; Guijarro LG; Prieto JC
    Ann N Y Acad Sci; 1996 Dec; 805():708-12. PubMed ID: 8993465
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of (3H)guanylylimidodiphosphate to membranes: lack of correlation with adenylate cyclase activation.
    Jacobs S; Cuatrecasas P
    Biochem Biophys Res Commun; 1976 Jun; 70(3):885-92. PubMed ID: 820343
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein and polypeptide hormones as inhibitors.
    Ramachandran J
    Life Sci; 1974 Mar; 14(6):993-1005. PubMed ID: 4362779
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
    Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR
    Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.